BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 9549198)

  • 1. [Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
    Lanas Arbeloa A; Serrano Aulló MT
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():20-4. PubMed ID: 9549198
    [No Abstract]   [Full Text] [Related]  

  • 2. Ulcer and gastritis.
    Anand BS; Graham DY
    Endoscopy; 1999 Feb; 31(2):215-25. PubMed ID: 10223377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications for the eradication of Helicobacter pylori. Reflections on the Maastricht consensus conference].
    Boixeda de Miquel D; Martín de Argila C; Pérez Gisbert J
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():29-34. PubMed ID: 9549200
    [No Abstract]   [Full Text] [Related]  

  • 4. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 6. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
    Carnicer J
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():25-8. PubMed ID: 9549199
    [No Abstract]   [Full Text] [Related]  

  • 12. [Peptic ulcer and drug therapy].
    Tsuneoka K
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):1-2. PubMed ID: 1673699
    [No Abstract]   [Full Text] [Related]  

  • 13. [Consequences of Helicobacter pylori infection on the incidence and treatment of gastro-duodenal ulcers in patients taking non-steroidal anti-inflammatory agents].
    Lamarque D
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1122-4. PubMed ID: 10051998
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 15. Peptic ulcer disease in the elderly.
    Cryer B; Feldman M
    Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Weilert F; Smith AC; Stokes PL
    N Engl J Med; 1998 Jul; 339(5):349; author reply 350-1. PubMed ID: 9696649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 18. The management of upper gastrointestinal problems in patients taking NSAIDs.
    Prichard P
    Aust Fam Physician; 1991 Dec; 20(12):1739-41. PubMed ID: 1687198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Chan FK; Sung JJ
    N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.